Sientra Inc (SIEN) Given Consensus Recommendation of “Buy” by Brokerages

Sientra Inc (NASDAQ:SIEN) has earned an average recommendation of “Buy” from the thirteen ratings firms that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $20.44.

A number of brokerages have recently commented on SIEN. BidaskClub upgraded Sientra from a “strong sell” rating to a “sell” rating in a research report on Monday, January 7th. Maxim Group upgraded Sientra from a “hold” rating to a “buy” rating in a research report on Wednesday, December 19th. ValuEngine downgraded Sientra from a “strong-buy” rating to a “buy” rating in a research report on Thursday, January 24th. William Blair downgraded Sientra from an “outperform” rating to a “market perform” rating in a research report on Wednesday, March 13th. Finally, Craig Hallum set a $23.00 price objective on Sientra and gave the company a “buy” rating in a research report on Tuesday, March 26th.

NASDAQ SIEN traded down $0.14 on Thursday, reaching $7.52. 609,712 shares of the stock traded hands, compared to its average volume of 740,759. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.75 and a current ratio of 2.12. The firm has a market cap of $219.67 million, a P/E ratio of -2.31 and a beta of -0.08. Sientra has a 12 month low of $7.10 and a 12 month high of $26.79.

Sientra (NASDAQ:SIEN) last announced its quarterly earnings data on Tuesday, March 12th. The medical instruments supplier reported ($0.86) EPS for the quarter, missing analysts’ consensus estimates of ($0.67) by ($0.19). Sientra had a negative net margin of 121.28% and a negative return on equity of 123.51%. The company had revenue of $19.02 million for the quarter, compared to analyst estimates of $18.87 million. On average, research analysts predict that Sientra will post -2.84 earnings per share for the current fiscal year.

Several large investors have recently made changes to their positions in SIEN. BlackRock Inc. lifted its holdings in shares of Sientra by 2.8% in the fourth quarter. BlackRock Inc. now owns 1,616,583 shares of the medical instruments supplier’s stock valued at $20,546,000 after purchasing an additional 43,684 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Sientra by 1.4% in the third quarter. Vanguard Group Inc. now owns 1,017,312 shares of the medical instruments supplier’s stock valued at $24,293,000 after purchasing an additional 14,422 shares in the last quarter. Vanguard Group Inc lifted its holdings in shares of Sientra by 1.4% in the third quarter. Vanguard Group Inc now owns 1,017,312 shares of the medical instruments supplier’s stock valued at $24,293,000 after purchasing an additional 14,422 shares in the last quarter. Millennium Management LLC lifted its holdings in shares of Sientra by 117.6% in the fourth quarter. Millennium Management LLC now owns 966,106 shares of the medical instruments supplier’s stock valued at $12,279,000 after purchasing an additional 522,153 shares in the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Sientra by 10.0% in the fourth quarter. Geode Capital Management LLC now owns 254,747 shares of the medical instruments supplier’s stock valued at $3,237,000 after purchasing an additional 23,117 shares in the last quarter. Institutional investors own 90.81% of the company’s stock.

About Sientra

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

Further Reading: How do buyers and sellers choose a strike price?

Analyst Recommendations for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.